PREDICT used to target risky imports

Vienna, Va. – In testimony to the Oversight and Investigations Subcommittee of the US House of Representatives Committee on Energy and Commerce, the Food and Drug Administration Commissioner Dr. Margaret Hamburg praised PREDICT, a solution supported by NTELX’s technology and analytical expertise.

Using FDA industry-specific knowledge, NTELX developed predictive targeting techniques, allowing the FDA to screen each shipment electronically to determine whether it meets the threshold for physical inspection or sampling, allowing the FDA to target hazardous products more accurately. In field testing, PREDICT has proven itself to be more rapid and accurate than the previous system. PREDICT is currently in use in the New York, Los Angeles, Seattle, and San Francisco–FDA districts covering approximately 40% of total imports to the United States.

About NTELX

NTELX serves high profile customers who face information overload and lack the resources to tackle it.   NTELX provides technology-driven solutions that transform a deluge of data into actionable intelligence directed to the right user at the right time, enabling clients to make faster and more accurate decisions in mission-critical environments.

About FDA

The Food and Drug Administration is the oldest comprehensive consumer protection agency in the US federal government. FDA’s modern regulatory functions began with the passage of the 1906 Pure Food and Drugs Act, a law a quarter-century in the making that prohibited interstate commerce in adulterated and misbranded food and drugs.